WEI Ya-qin, WANG Tian-yun, LI Ya-ting, CHEN Yu-lang, LIAO Wen-xing, DU Yan, TANG Dao-quan. Metabolites of schaftoside in mouse plasma, bile, urine and feces after oral administration by UPLC-Q/TOF-MS/MSJ. Acta Pharmaceutica Sinica, 2022, 57(9): 2811-2820. DOI: 10.16438/j.0513-4870.2022-0436
Citation: WEI Ya-qin, WANG Tian-yun, LI Ya-ting, CHEN Yu-lang, LIAO Wen-xing, DU Yan, TANG Dao-quan. Metabolites of schaftoside in mouse plasma, bile, urine and feces after oral administration by UPLC-Q/TOF-MS/MSJ. Acta Pharmaceutica Sinica, 2022, 57(9): 2811-2820. DOI: 10.16438/j.0513-4870.2022-0436

Metabolites of schaftoside in mouse plasma, bile, urine and feces after oral administration by UPLC-Q/TOF-MS/MS

  • Ultra-high performance liquid chromatography coupled with quadrupole/time-of-flight tandem mass spectrometry (UPLC-Q/TOF-MS/MS) has been used to detect the metabolites of schaftoside in plasma, bile, urine and feces of mice after oral administration. The study was approved by the Experimental Animal Ethics Committee from Xuzhou Medical University (No. XZMULL201612024). Compounds were identified by analyzing their high-resolution mass spectrometry data, mass spectra, and comparison with reference substances and the literatures. The parent compound and 29 metabolites were detected in the plasma, bile, urine and feces samples of mice. The main metabolic pathways of schaftoside in mice include deglycosylation/glycosylation, hydroxylation/dehydroxylation, hydrogenation, methylation, acetylation, sulfation, and glucuronidation. This study provides references for the material basis of schaftoside in vivo.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return